2,000
Participants
Start Date
October 3, 2016
Primary Completion Date
December 31, 2034
Study Completion Date
December 31, 2034
Active surveillance
Active monitoring of prostate cancer and curative treatment if there are signs of tumor progression.
Rigshospitalet, Copenhagen
Odense University Hospital, Odense
Helsinki University Hospital, Helsinki
Seinäjoki Central Hospital, Tampere
Ålesund Regional Hospital, Ålesund
Oslo University Hospital, Oslo
University Hospital of North Norway, Tromsø
St Olavs University Hospital, Trondheim
Hospital of Vestfold, Tønsberg
Sahlgrenska University Hospital, Gothenburg
Linköping University Hospital, Linköping
Sunderby Regional Hospital, Luleå
Örebro University Hospital, Örebro
Sundsvall Regional Hospital, Sundsvall
Umeå University Hospital, Umeå
Akademiska University Hospital, Uppsala
Växjö Hospital, Vaxjo
Bedford Hospital, Bedford
Croydon University Hospital, Croydon
Epsom and St Helier Hospital, London
Guy's Hospital, London
Queen Elisabeth Hospital, London
Royal Marsden Hospital, London
Uppsala University
OTHER